Pharmafile Logo
Pharmafocus logo
Advanced Search

Merck KGaA

Showing 15 posts of 91 posts found.

Merck KGaA appoints Frederic Wohlwend

February 7, 2011
Sales and Marketing Frederic Wohlwend, Merck KGaA, appointment, sales and marketing

Frederic Wohlwend has been promoted to chief information officer at Merck KGaA with effect from 1 April. He succeeds Kai …

Appointment

Novartis MS drug steals march over Merck rival

January 24, 2011
Sales and Marketing Cladribine, MS, Merck KGaA, Novartis, fingolimod, gilenya, multiple sclerosis

Novartis’ oral multiple sclerosis Gilenya could be on the European market in just three months after winning the backing of …

News

Merck Serono and Domain to co-develop Parkinson’s drugs

January 18, 2011
Research and Development Domain Therapeutics, Merck KGaA, Merck Serono, PAM, Parkinson's disease, Parkinson’s disease, Positive Allosteric Modulator, mGluR4, metabotropic glutamate receptor 4

Merck Serono is to work with French biotech company Domain Therapeutics to develop a new treatment for Parkinson’s disease and …

News

Merck KGaA opens outsourcing centre in India

January 5, 2011
Research and Development Application and Technology Centre, India, Merck KGaA, Merck Millipore, Millipore, outsourcing

Merck KGaA has opened a new technology centre near Mumbai in India that will offer a range of research services …

News

Merck KGaA appoints new head of pharma

December 17, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Elmar Schnee, Merck KGaA, Merck Serono, Stefan Oschmann, appoinment, manufacturing and production, research and development, sales and marketing

Merck KGaA has appointed Stefan Oschmann head of its pharmaceuticals division Merck Serono. He takes office on 1 January 2011 …

Appointment

FDA approves Merck’s HIV fat drug Egrifta

November 12, 2010
Research and Development, Sales and Marketing EMD Serono, Egrifta, FDA, HIV, Merck KGaA, abdominal fat in HIV, tesamorelin

US regulatory authorities have approved the first treatment indicated to target abdominal fat in patients with HIV after trials showed …

News

Merck will appeal EMA’s Movectro decision

October 12, 2010
Sales and Marketing CHMP, EMA, Merck KGaA, Merck Serono, Movectro

Merck KGaA is poised to appeal the EMA’s decision on its MS treatment Movectro after the regulator rejected the drug …

News

Merck KGaA’s oral MS therapy gains US priority review

July 29, 2010
Sales and Marketing Cladribine, MS, Merck KGaA

Merck’s cladribine has been granted a priority review status by the FDA in a move that could see it come …

News

Merck Millipore unveiled as $7bn acquisition completed

July 20, 2010
Manufacturing and Production Merck KGaA, Millipore

Germany’s Merck KGaA has completed its $7 billion acquisition of processing equipment specialist Millipore, officially launching the combined Merck Millipore …

News

Merck Serono resubmits oral MS therapy to FDA

June 8, 2010
Research and Development Cladribine, MS, Merck KGaA

Merck Serono has re-submitted its oral multiple sclerosis therapy cladribine to US regulators. Merck Serono, a Swiss division of Merck …

News

Merck bounces back

April 28, 2010
Sales and Marketing Merck KGaA

Merck KgaA tripled its profit year-on-year in the first quarter of 2010, largely on the back of a better than …

News

Trial boost for Merck KGaA’s cladribine

April 19, 2010
Research and Development Cladribine, MS, Merck KGaA, Merck Serono

New data from German pharma company Merck suggests its oral multiple sclerosis treatment cladribine has been successful in treating relapsing …

News

Adverse event halts Merck cancer vaccine trial

March 23, 2010
Research and Development Merck KGaA, Merck Serono, Stimuvax, vaccines

Trials of a new vaccine which helps fight cancer have been halted after one patient developed encephalitis, a potentially fatal …

News
Merck KGaA

Merck KGaA invests in bioresearch and bioproduction

March 1, 2010
Manufacturing and Production, Research and Development Biochemistry, Merck KGaA, Merck Serono, Millipore, laboratory services

Merck KGaA has bought US life sciences company Millipore Corporation in a $7.2 billion deal to expand its chemicals business. …

News

Merck KGaA posts modest revenue increase

February 24, 2010
2009 financials, Erbitux, Merck KGaA, Merck Serono, Rebif

German pharma company Merck has posted a modest rise in revenue amidst strong pharma growth.  Revenues increased 2.1% to 7.7 …

News

Latest content

GSK shares data from global shingles survey

December 1, 2023

AbbVie to acquire ImmunoGen for approximately $10.1bn

December 1, 2023

FDA accepts NDA for Karuna’s schizophrenia treatment

November 30, 2023

Vivos Therapeutics gains FDA 510(k) clearance for sleep apnea treatment device

November 30, 2023

Tolremo doses first patient in phase 1 trial for drug to combat transcriptional cancer drug resistance

November 29, 2023